This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Sbi Biotech Co., Ltd., Wakayama Medical University. Active years: 2016-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 14 
1 out of 1 Years Active: 2016-2020
Title: Ayumi Kotaki: A Pioneer in Immunotherapy Innovations
Introduction
Ayumi Kotaki, an accomplished inventor based in Tokyo, Japan, has made significant contributions to the field of immunotherapy. With two notable patents to her name, she has developed innovative solutions aimed at addressing various immune-mediated disorders.
Latest Patents
Ayumi's latest patents demonstrate her commitment to advancing medical science. The first patent focuses on TLR inhibitory oligonucleotides and their use. These oligonucleotides, with partial phosphorothioation, exhibit reduced toxicity and effectively block NF-kB activation induced by TLR9 and TLR7/8 agonists. This groundbreaking work inhibits the production of pro-inflammatory cytokines such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNFa). Moreover, it prevents the Interferon (IFN) production from human PBMC induced by TLR9 agonists. These oligonucleotides show promise as remedies for immune-mediated disorders, including rheumatoid arthritis, systemic lupus erythematosus (SLE), sepsis, multiple organ dysfunction syndromes, and other inflammatory diseases.
Her second patent involves an anti-oncostatin M receptor beta antibody specifically designed for treating atopic dermatitis. This monoclonal antibody targets the oncostatin M specific receptor beta subunit and holds the potential to improve treatment outcomes for patients suffering from this condition.
Career Highlights
Throughout her career, Ayumi Kotaki has worked with distinguished organizations, including Sbi Biotech Co., Ltd. and Wakayama Medical University. Her industry experience has enriched her understanding and approach to innovative therapeutic strategies in immunology.
Collaborations
Ayumi has collaborated with esteemed colleagues such as Eiji Esashi and Yoshihiro Morikawa. These partnerships have fostered an environment of innovation and have facilitated her advancements in the field.
Conclusion
As an inventor, Ayumi Kotaki continues to push the boundaries of immunotherapy with her innovative patents. Her dedication to addressing complex healthcare challenges is commendable and highlights the critical role that inventors play in advancing medical science. With her expertise and collaborative spirit, she is poised to make further contributions to the healthcare industry, offering hope to those affected by immune-mediated disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile